Your browser doesn't support javascript.
loading
Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade Using Tissue Cyclic Immunofluorescence: A Pilot Study.
Maliga, Zoltan; Kim, Daniel Y; Bui, Ai-Tram N; Lin, Jia-Ren; Dewan, Anna K; Jadeja, Saagar; Murphy, George F; Nirmal, Ajit J; Lian, Christine G; Sorger, Peter K; LeBoeuf, Nicole R.
Afiliación
  • Maliga Z; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
  • Kim DY; Harvard-MIT Health Sciences and Technology Program, Harvard Medical School, Boston, Massachusetts, USA.
  • Bui AN; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Lin JR; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
  • Dewan AK; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Jadeja S; Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Murphy GF; Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Nirmal AJ; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
  • Lian CG; Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Sorger PK; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
  • LeBoeuf NR; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: nleboeuf@partners.org.
J Invest Dermatol ; 144(8): 1887-1890.e5, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38360200

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico Idioma: En Revista: J Invest Dermatol Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico Idioma: En Revista: J Invest Dermatol Año: 2024 Tipo del documento: Article